Clinical factors associated with the occurrence of nausea and vomiting in type 2 diabetes patients treated with glucagon‐like peptide‐1 receptor agonists
Abstract Aims/Introduction Research has proved a correlation between glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and gastrointestinal adverse events. Predominantly, nausea and vomiting are frequent gastrointestinal adverse events that lead to the discontinuation of GLP‐1 RAs treatment. The...
Main Authors: | Megumi Shiomi, Tesshu Takada, Yoichi Tanaka, Keiko Yajima, Akira Isomoto, Masaki Sakamoto, Katsuya Otori |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-03-01
|
Series: | Journal of Diabetes Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1111/jdi.12900 |
Similar Items
-
Postoperative nausea and vomiting
by: Young Eun Moon
Published: (2014-09-01) -
Prevention of Nausea and Vomiting in Oncology
by: AV Snegovoi, et al.
Published: (2016-01-01) -
Incidence of Nausea and Vomiting After Fast-Track Anaesthesia for Heart Surgery
by: Emad Mohamed Hijazi, et al. -
Nausea in Specific Phobia of Vomiting
by: Eugen Trinka, et al.
Published: (2013-08-01) -
Dexasone and metoclopramide vs. granisetron in the prevention of postoperative nausea and vomiting
by: Bagi Bojan, et al.
Published: (2019-01-01)